12The Non-Auditory Side-Effect Problem

FHearing’s noisy neighbourhood

The cochlear nucleus is not an isolated island. It sits on the surface of the brainstem packed against the cerebellar peduncles, the facial and trigeminal pathways, the lower cranial nerves, the vestibular nuclei and long sensory tracts carrying touch from the whole body. A cochlear-implant electrode lives inside the bony cochlea, walled off from such structures; an ABI electrode lies on an open surface where its current can spread a millimetre or two into tissue that has nothing to do with hearing.

The result is a catalogue of non-auditory sensations: tingling or pulling in the head or body, sudden jerks, dizziness, a sensation of vibration in the eye, throat or chest sensations, and facial sensation or twitching. These are not malfunctions of the device. They are the predictable price of stimulating a crowded piece of neural real estate, and over ninety percent of recipients experience some non-auditory effect when their electrodes are tested.[2002][2008]

THow side-effects steal channels

Every electrode that produces an intolerable non-auditory sensation has to be switched off, and that directly shrinks the number of independent channels available to carry sound. In the House Ear Institute experience, roughly a quarter of individual electrodes on implanted arrays could not be used because of non-auditory effects such as dizziness, tingling, pulling sensations and visual jittering. Across reported series the proportion of recipients affected has ranged widely, with some studies finding non-auditory side-effects in around half to more than two-thirds of recipients.

This is why intraoperative placement and careful programming matter so much: the usable channel count is set less by how many electrodes the array carries than by how many escape non-auditory contamination. The penetrating ABI was developed partly to attack this problem, by reaching auditory neurons more focally at lower current it aims to recruit fewer non-target structures, although it trades that focus for added complexity.[2002][2010]

CIdentifying and managing the offenders

Side-effects are mapped electrode by electrode at activation, with the patient describing exactly what each contact produces. Several levers can tame a contaminated electrode before it is abandoned. Changing the reference electrode and reducing or shaping the pulse, particularly pulse duration, can narrow current spread; lowering the comfort level can keep an electrode below its side-effect threshold while still useful. Only when an electrode is auditory-useless or intolerable at every workable setting is it permanently switched off.

Time is a powerful ally. Many non-auditory sensations diminish over the months after activation, so electrodes that were intolerable at first can sometimes be reintroduced later, recovering channels. Because of these dynamics, ABI maps are revisited repeatedly rather than fixed once, and the audiologist counsels the recipient that the side-effect burden is expected to ease with adaptation and experience.[2008][2012]

CWhy this differs fundamentally from the cochlear implant

Cochlear implants are not entirely free of non-auditory effects, the classic example being facial-nerve stimulation, where current escapes the cochlea to the nearby facial nerve and is usually fixable by deactivating or reprogramming the one or few offending electrodes. But this is the exception, affecting a minority of users and a minority of electrodes, and the device still has a stable, tonotopically ordered cochlea to work with.

For the ABI the problem is structural, not incidental. The electrode sits among non-auditory structures by design, the variety of possible side-effects is far wider than facial twitching alone, and the loss of channels is large enough to be a primary determinant of outcome. Where a cochlear implant occasionally sheds an electrode to a side-effect, an ABI’s entire usable map is sculpted around avoiding them, which is one of the deepest reasons ABI hearing typically falls short of cochlear-implant hearing.[2009][2002]